Ramalingam begins new role as Winship executive director

Suresh Ramalingam, MD, who became executive director of Winship Cancer Institute on July 1, reflects on his new role and taking the helm at a transformational moment for Winship, Georgia's NCI-designated comprehensive cancer center.

Gillespie named associate director for community outreach and engagement

Theresa W. Gillespie, PhD, MA, BSN, has been named Winship's new associate director for community outreach and engagement. Gillespie will provide vision and oversight for Winship’s community-facing priorities, including cancer health disparities, clinical trials access, and cancer risk mitigation, prevention, and control.

View Profile

Jani and Ritenour awarded Kennedy professorships

Ashesh B. Jani, MD, and Chad W.M. Ritenour, MD, have been selected for James C. Kennedy professorships at Emory University School of Medicine. Jani was named James C. Kennedy Professor in Prostate Cancer, and Ritenour was named James C. Kennedy Professor in Prostate Health. They were honored in a virtual ceremony on June 29.

Emory physicians make up almost half of 2021 'Top Doctors' list in Atlanta magazine

Almost 50 percent of the physicians recognized in the 2021 “Top Doctors” issue of Atlanta magazine are physicians within Emory Healthcare, Emory Healthcare Network, Emory medical staff, or faculty of Emory University School of Medicine.

NCI funds study of new targeted lung cancer treatment

Xingming Deng, MD, PhD, and colleagues have received a five-year, $2.2 million grant from the National Cancer Institute (NCI) to investigate a new therapeutic avenue for treating lung cancer. The study focuses on Mcl-1, a protein that cancer cells rely on for survival and DNA damage repair.

Registration opens for Winship Win the Fight 5K

Registration is officially open for the Annual Winship Win the Fight 5K Run/Walk! This year's race will be held both in person and virtually on Oct. 2, 2021. Register today and join a team to take part in activities and challenges leading up to race day.

Emory OTT celebrates year of innovations

Emory’s Office of Technology Transfer (OTT) announced the recipients of its annual awards on June 30. Winship members were recognized for their contributions to the Innovation of the Year (Serological Test for SARS-CoV-2) and Start-up of the Year (IN8bio – Series A Financing).

View Awardees

Lowe throws out first pitch at Braves game

Michael Lowe, MD, threw out the first pitch at the Atlanta Braves game on July 2, as part of Emory Healthcare's partnership with the Atlanta Braves to promote sun safety. Lowe specializes in treating cutaneous malignancies, including melanoma, basal cell carcinoma, and Merkel cell carcinoma.

About Sun Safety

Winship to host two-day K12 skill building and orientation workshop

The Winship K12 Clinical Oncology Training Program will host its annual K12 Intensive Skill Building and Orientation Workshop July 15-16. This free virtual workshop will provide intensive training in cancer clinical research methods for early career investigators.

Call for applicants: Cancer Animal Models technical director

Cancer Animal Models, one of Winship’s 11 shared resources, is hiring a technical director. The technical director will work with investigators and staff to design, develop, and implement specialized technical approaches to animal models for cancer research.

View Job Listing

Seminar series explores fluorescence imaging

The Integrated Cellular Imaging Shared Resource is continuing its free, six-part virtual education series covering the entire workflow of quantitative fluorescence imaging for researchers. The next µTalk, “Advanced Labeling Protocols,” will be held on July 9 at 1 p.m.

Learn More

EIGC webinar to feature MaxCyte electroporation technology

The Emory Integrated Genomics Core (EIGC) is hosting MaxCyte for a technical webinar on July 7 at 11 a.m. Learn more about MaxCyte’s electroporation technology, which performs rapid transfections for thousands to millions of cells.

Learn More

Below are four selected Winship publications out of 65 published over the past week:

Yabroff KR, Wu XC, Negoita S, Stevens J, Coyle L, Zhao J, Mumphrey BJ, Jemal A, Ward KC. Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services. Journal of the National Cancer Institute. 2021; PubMed PMID: 34181001.

View in PubMed

Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Annals of Surgery. 2021; 274(1):e28-e35. PubMed PMID: 31356277.

View in PubMed

Marks JA, Switchenko JM, Martini DJ, Tarabadkar ES, Khan MK, Lechowicz MJ, Allen PB. T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma. JAMA Dermatology. 2021; PubMed PMID: 34190977.

View in PubMed

Qian G, Guo J, Vallega KA, Hu C, Chen Z, Deng Y, Wang Q, Fan S, Ramalingam SS, Owonikoko TK, Wei W, Sun SY. Membrane-associated RING-CH 8 functions as a novel PD-L1 E3 ligase to mediate PD-L1 degradation induced by EGFR inhibitors. Molecular Cancer Research. 2021; PubMed PMID: 34183449.

View in PubMed